ANIK vs. OFIX, ANGO, SIBN, ARAY, SRDX, ATRI, OSUR, CERS, UTMD, and WST
Should you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Orthofix Medical (OFIX), AngioDynamics (ANGO), SI-BONE (SIBN), Accuray (ARAY), Surmodics (SRDX), Atrion (ATRI), OraSure Technologies (OSUR), Cerus (CERS), Utah Medical Products (UTMD), and West Pharmaceutical Services (WST). These companies are all part of the "surgical & medical instruments" industry.
Anika Therapeutics (NASDAQ:ANIK) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
In the previous week, Orthofix Medical had 1 more articles in the media than Anika Therapeutics. MarketBeat recorded 3 mentions for Orthofix Medical and 2 mentions for Anika Therapeutics. Anika Therapeutics' average media sentiment score of 0.77 beat Orthofix Medical's score of 0.42 indicating that Anika Therapeutics is being referred to more favorably in the media.
91.5% of Anika Therapeutics shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 5.9% of Anika Therapeutics shares are owned by insiders. Comparatively, 4.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Orthofix Medical has a net margin of -16.64% compared to Anika Therapeutics' net margin of -45.39%. Anika Therapeutics' return on equity of 0.48% beat Orthofix Medical's return on equity.
Anika Therapeutics currently has a consensus price target of $30.50, suggesting a potential upside of 20.51%. Orthofix Medical has a consensus price target of $18.00, suggesting a potential upside of 36.99%. Given Orthofix Medical's higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Anika Therapeutics.
Anika Therapeutics has higher earnings, but lower revenue than Orthofix Medical. Anika Therapeutics is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.
Anika Therapeutics has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.
Orthofix Medical received 111 more outperform votes than Anika Therapeutics when rated by MarketBeat users. However, 64.24% of users gave Anika Therapeutics an outperform vote while only 61.80% of users gave Orthofix Medical an outperform vote.
Summary
Anika Therapeutics and Orthofix Medical tied by winning 9 of the 18 factors compared between the two stocks.
Get Anika Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ANIK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Anika Therapeutics Competitors List
Related Companies and Tools
